Opposing roles for TGF-β1 and TGFβ3 isoforms in experimental autoimmune encephalomyelitis

Cytokine

Volumn 25, Issue 2, 2004, Pages 45-51

  Matejuk, Agata ^a,b   Dwyer, Jami ^b   Hopke, Corwyn ^b   Vandenbark, Arthur A ^a,b,c   Offner, Halina ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

EAE; Estrogen; TGF 1; TGF 3

Indexed keywords

ENCEPHALITOGENIC PROTEIN; ESTRADIOL; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; INFLAMMATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPLEEN;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0346881201     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.09.007     Document Type: Article

References (39)

1. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med. 176:1992;1355-1364.
2. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in the SJL and B10.PL mice. Proc Natl Acad Sci U S A. 89:1992;574-578.
3. 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 177:1993;57-68.
4. Racke M.K., Dhib-Jalbut S., Cannella B., Albert P.S., Raine C.S., McFarlin D.E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol. 146:1991;3012-3017.
5. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
6. Piccinni M.P., Giudizi M.G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., et al. Progesterone favors the development of T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 155:1995;128-133.
7. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 158:1997;446-451.
8. Araneo B.A., Dowell D., Diegel M., Daynes R.A. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5 and γ-interferon, but not IL-2 by activated murine T cells. Blood. 78:1991;688-699.
9. Jansson L.T., Olsson T., Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol. 53:1994;203-207.
10. Trooster W.J., Teelken A.W., Kampinga J., Loof J.G., Nieuwenhuis P., Minderhoud J.M. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: an immunological study in the Lewis rat. Int Arch Allergy Immunol. 102:1993;133-140.
11. Dalal M., Kim S., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper bias in the autoantigen-specific T lymphocyte response. J Immunol. 159:1997;3-6.
12. Nagaeva O., Jonsson L., Mincheva-Nilsson L. Dominant IL-10 and TGF-β mRNA expression in γδT cells of human early pregnancy deciduas suggests immunoregulatory potential. Am J Reprod Immunol. 48:2002;9-17.
13. Salem M.L., Matsuzaki G., Madkour G.A., Nomoto K. Beta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice. Int J Immunopharmacol. 21:1999;481-497.
14. Saito K., Ohtsu Y., Amano K., Nishijima M.J. Perinatal outcome and management of single fetal death in twin pregnancy: a case series and review. J Perinat Med. 27:1999;473-477.
15. Messague J., Attisano L., Wrana J.L. The TGF-β superfamily and its composite receptors. Trends Cell Biol. 4:1994;172-176.
16. Messague J., Weis-Garcia F. TGF-βs in cancer. Pawson T., Parker A. Cancer surveys. 1996;620-623 ICRF Press, London.
17. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
18. Constam D.B., Philipp J., Malipiero U.V., Ten D.P., Schachner M., Fontana A. Differential expression of transforming growth factor-beta 1, -beta 2 and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol. 148:1992;1404-1410.
19. Logan A., Frautschy S.A., Gonzalez A.M., Sporn M.B., Baird A. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
20. Roberts A.B., Sporn M.B. Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev. 32:1992;91-98.
21. Johns L.D., Sriram S. Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol. 47:1993;1-7.
22. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol. 117:1992;395-400.
23. Chen T.C., Hinton D.R., Yong V.W., Hofman F.M. TGF-β2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells. J Neuroimmunol. 73:1997;155-161.
24. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., et al. Oral tolerance: immunogenic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 12:1994;809-937.
25. Johns L.D., Flanders K.C., Ranges G.E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor 1. J Immunol. 147:1991;1792-1800.
26. Racke M.K., Cannella B., Albert P., Sporn M., Raine C.S., McFarlin D.E. Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol. 4:1992;615-620.
27. Chen L.Z., Hochwald G.M., Huang C., Dakin G., Tao H., Cheng C., et al. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1. Proc Natl Acad Sci U S A. 95:1998;12516-12521.
28. Mustafa M., Vingsbo C., Olsson T., Issazadeh S., Ljungdahl A., Holmdahl R. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. J Immunol. 153:1994;3337-3344.
29. Kjellen P., Issazadeh S., Olsson T., Holdahl R. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis. Int Immunol. 10:1998;333-340.
30. Rimaniol A.C., Lekieffre D., Serrano A., Masson A., Benavides J., Zavala F. Biphasic transforming growth factor β production flanking the pro-inflammatory cytokine response in cerebral trauma. Neuroreport. 7:1995;133-136.
31. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P., Sirimanne E., et al. Neuronal rescue with transforming growth factor beta 1 after hypoxic-ischemic brain injury. Neuroreport. 5:1994;901-904.
32. Krupinski J., Kumar P., Kumar S., Path F.R.C., Kaluza J. Increased expression of TGF-β1 in brain tissue after ischemic stroke in human. Stroke. 27:1996;852-857.
33. Sentambrogio L., Hochwald G.M., Saxena B., Leu C.-H., Martz J.E., Carlino J.A., et al. Studies on mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J Immunol. 151:1993;1116-1127.
34. Vivien D., Bernaudin M., Buisson A., Divoux D., MacKenzie E.T., Nouvelot A. Evidence of type I and type II transforming growth factor-β receptors in central nervous tissues: changes induced by focal cerebral ischemia. J Neurochem. 70:1998;2296-2304.
35. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β Annu Rev Immunol. 16:1998;137-161.
36. Olivares-Villagomez D., Wang Y., Laffaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med. 188:1998;1883-1894.
37. Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., Offner H. 17β-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res. 65:2001;529-542.
38. Ito A., Buenafe A.C., Matejuk A., Zamora A., Silverman M., Dwyer J., et al. Estrogen inhibits systemic T cell expression of TNF-α and recruitment of TNF-α+ T cells and macrophages into the CNS of mice developing experimental encephalomyelitis. Clin Immunol. 102:2002;275-282.
39. Bebo B.F. Jr., Vandenbark A.A., Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res. 45:1996;680-689.